WEBINAR REPLAY

Epidemics Meet a Pandemic: How COVID-19 is Impacting Alcohol and Substance Use

Learn how the pandemic is affecting alcohol and substance use and how employers can both support employees who are struggling

What You’ll Learn in this On-Demand Replay

Across the U.S., 13% of people report starting or increasing substance use to cope with the overwhelming stress and emotions related to COVID-19. Substance use was already an epidemic, and with the recent increased use, decreased social support, and closure of inpatient treatment facilities fueled by the pandemic it has made it even harder for those who are struggling.

Join clinicians and substance use experts Smita Das, MD, PhD, MPH and Liz Rojas, PhD, to learn why substance use is increasing during the pandemic, the impact it could have long term, and what employers can do to better support their employees.

In this on-demand webinar you’ll learn:

  • The epidemiology of substance use disorders before, during, and the long after COVID-19
  • How both mental health and substance use disorders can contribute to one another
  • The values that drive their well-being strategy for physical, personal, and financial health and growth
  • An inside look at evidence-based approaches to treating substance use disorders
  • How employers can help prevent substance use issues from escalating into significant impairment with effective behavioral health support

Featured Speakers

Sherice Torres

Global Director of Inclusion, Google

Nikki Smith-Bartley

Chief Diversity & Talent Strategy Officer, Asurion

Andrea Holman, PhD

Associate Professor of Psychology, Huston-Tillotson University

Featured Speakers

Smita Das, MD, PhD, MPH

Medical Director, Psychiatry, Lyra Health

Liz Rojas, PhD

Clinical Manager for Blended Care Therapy, Lyra Health

Featured Speakers

Sherice Torres

Global Director of Inclusion, Google

About the Panel

Smita Das, MD, PhD, MPH

Dr. Das is Board Certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine and has 20 years of experience in healthcare quality and addiction research. She studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She has been a leader in psychiatry, is the immediate past president of the Northern California Psychiatric Society and serves on the Addiction Council of the American Psychiatric Association (APA). Prior to her position as Medical Director of Psychiatry at Lyra Health, she was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Assistant Professor.

Liz Rojas, PhD

Dr. Rojas oversees the clinical quality and training development for the Blended Care Program. She went to graduate school for her doctorate in clinical psychology at the University of South Florida, where she researched assessments for personality disorders. She then completed her internship at the San Diego VA and post-doctoral fellowship at the Palo Alto VA, where she specialized in the treatment of substance use disorders and PTSD. Prior to joining Lyra, she served on the clinical staff for the Substance Abuse Residential Rehabilitation Program at the Palo Alto VA.